Catalyst Wire Dossier Catalyst Wire Dossier

Formoterol/Budesonide 12/400 mcg via Discair

formoterol/budesonide
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Formoterol/Budesonide 12/400 mcg via Discair, covering 2020-06-16 to 2020-06-16. Get the full timeline:

Most recent: Clinical Trial Update: Assessment of Bronchodilator Efficacy of Formoterol/Budesonide 12/400 mcg Via Discair in COPD [Phase 4]

See pricing